Artigos com autorizações de acesso público - Martin BergstrandSaiba mais
Disponíveis em algum local: 6
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention
M Bergstrand, F Nosten, KM Lwin, MO Karlsson, NJ White, J Tarning
Science translational medicine 6 (260), 260ra147-260ra147, 2014
Autorizações: Swedish Research Council, Wellcome Trust
Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine
J Permala, J Tarning, F Nosten, NJ White, MO Karlsson, M Bergstrand
Antimicrobial Agents and Chemotherapy 61 (5), 10.1128/aac. 02491-16, 2017
Autorizações: Wellcome Trust
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
JP Lohy Das, MP Kyaw, MH Nyunt, K Chit, KH Aye, MM Aye, MO Karlsson, ...
Malaria Journal 17, 1-10, 2018
Autorizações: Bill & Melinda Gates Foundation, Wellcome Trust
Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
J Lohy Das, AM Dondorp, F Nosten, AP Phyo, W Hanpithakpong, ...
The AAPS Journal 19, 1842-1854, 2017
Autorizações: Bill & Melinda Gates Foundation, Wellcome Trust
External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients
D Rekić, D Röshammar, M Bergstrand, J Tarning, A Calcagno, A D’Avolio, ...
The AAPS journal 15, 308-315, 2013
Autorizações: Swedish Research Council, Wellcome Trust
Population Pharmacokinetic and Pharmacodynamic Properties of Artesunate in Patients with Artemisinin Resistant Infections in Southern Myanmar
J Lohy Das, MP Kyaw, M Nyunt, K Chit, K Aye, M Aye, MO Karlsson, ...
Malaria Journal 17, 2018
Autorizações: Bill & Melinda Gates Foundation, Wellcome Trust
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.